Financials Circio Holding ASA

Equities

TRVX

NO0013033795

Biotechnology & Medical Research

Market Closed - Oslo Bors 10:45:00 2024-04-26 am EDT 5-day change 1st Jan Change
2.7 NOK +0.75% Intraday chart for Circio Holding ASA -6.90% -62.50%

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 555.2 837.6 416.2 206.6 51.58 20.56 - -
Enterprise Value (EV) 1 538.5 776.4 293 201.1 51.58 -148.4 -24.65 20.56
P/E ratio -3.6 x -6.91 x -2.01 x -2.03 x -0.44 x 0.46 x -1.27 x -
Yield - - - - - - - -
Capitalization / Revenue 247 x 1,342 x - 20.7 x 419 x 0.1 x 0.22 x 0.08 x
EV / Revenue 239 x 1,244 x - 20.1 x 419 x -0.74 x -0.27 x 0.08 x
EV / EBITDA -3.68 x -7.75 x -3.11 x -1.99 x -0.52 x 343 x 0.7 x 0.21 x
EV / FCF -3,564,339 x -7,002,948 x -3,430,373 x - - - - -
FCF Yield -0% -0% -0% - - - - -
Price to Book - 2.25 x 1 x 0.62 x - 4.74 x 67.5 x -
Nbr of stocks (in thousands) 2,113 2,884 6,278 6,282 7,164 7,614 - -
Reference price 2 262.8 290.4 66.30 32.88 7.200 2.700 2.700 2.700
Announcement Date 3/11/20 2/18/21 2/17/22 2/16/23 4/25/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2.251 0.624 - 10 0.123 200 93 272
EBITDA 1 -146.2 -100.2 -94.29 -100.9 -98.73 -0.4333 -35 98
EBIT 1 -150.3 -103.9 -95.6 -102.3 -100.5 8.735 -66.16 -
Operating Margin -6,675.83% -16,650.8% - -1,022.44% -81,709.76% 4.37% -71.13% -
Earnings before Tax (EBT) 1 -147.8 -108.4 -98.02 -102.6 -110.7 7.765 -67.18 -
Net income 1 -147.5 -108.1 -97.97 -102.5 -110.7 -1.823 -67.18 198
Net margin -6,553.93% -17,327.88% - -1,025.16% -90,029.27% -0.91% -72.24% 72.79%
EPS 2 -72.90 -42.00 -33.00 -16.20 -16.33 5.824 -2.129 -
Free Cash Flow -151.1 -110.9 -85.4 - - - - -
FCF margin -6,711.59% -17,766.51% - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share 2 - - - - - - - -
Announcement Date 3/11/20 2/18/21 2/17/22 2/16/23 4/25/24 - - -
1NOK in Million2NOK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2019 S1 2020 S1 2021 S1 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales 1 0.012 0.59 - - - - - - 10
EBITDA 1 -82.18 -56.96 -45.51 -22.2 -25.18 -28.73 -30.38 -19.94 -21.81
EBIT 1 - -58.99 - -22.54 -25.52 -29.07 -30.71 -20.28 -22.2
Operating Margin - -9,998.14% - - - - - - -221.92%
Earnings before Tax (EBT) 1 -86.67 -59.36 -48.05 -23.32 -26.65 -30.45 -29.18 -20.74 -22.21
Net income 1 -86.51 -59.21 -48.02 -23.31 -26.64 -30.44 -29.16 -20.73 -22.2
Net margin -720,883.33% -10,036.27% - - - - - - -222%
EPS 2 -44.70 -24.00 -16.50 -8.100 -8.400 -4.800 -4.500 -3.300 -3.600
Dividend per Share - - - - - - - - -
Announcement Date 8/22/19 8/20/20 8/18/21 11/4/21 2/17/22 5/12/22 8/18/22 11/3/22 2/16/23
1NOK in Million2NOK
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - - - -
Net Cash position 1 16.7 61.3 123 5.48 - 169 45.2 -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow -151 -111 -85.4 - - - - -
ROE (net income / shareholders' equity) -43.9% -32.4% -24.8% -27.3% - -9.97% -93.4% -
ROA (Net income/ Total Assets) -29.7% -22.2% -18% -19.4% - 13.9% -9.8% -
Assets 1 497.3 487.6 543 528.5 - -13.12 685.5 -
Book Value Per Share 2 - 129.0 66.50 53.00 - 0.5700 0.0400 -
Cash Flow per Share - - - - - - - -
Capex 1 0.13 0.07 - - - 0.5 0.51 -
Capex / Sales 5.95% 11.22% - - - 0.25% 0.55% -
Announcement Date 3/11/20 2/18/21 2/17/22 2/16/23 4/25/24 - - -
1NOK in Million2NOK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
2
Last Close Price
2.7 NOK
Average target price
48 NOK
Spread / Average Target
+1,677.78%
Consensus
  1. Stock Market
  2. Equities
  3. TRVX Stock
  4. Financials Circio Holding ASA